CME Group Inc. (NASDAQ:CME) on the Path to Ruin

The CME Group Inc. (CME) shares are trading at lower $167.50 and the avg recommendation for the stock is Moderate Buy. while the current analyst …

The CME Group Inc. (CME) shares are trading at lower $167.50 and the avg recommendation for the stock is Moderate Buy. while the current analyst price target stands at $188.00.

To add more color to this target, the company’s high over the last year is $225.36 and the low is $131.80. Over the last 52 weeks, CME is down -25.67% while the S&P 500 is up 0.73%. The catalyst for this interesting swing was the company’s recent earnings report.

A Notable Earnings Report

In the last quarter, CME reported a profit of $562.2 million. CME Group Inc. also saw revenues increase to $1.52 billion. In addition, CME has free cash flow of $714.3 million as of 03-2020. The company’s EBITDA came in at $1.07 billion which compares well with its peers.

CME booked profit margins of 45.80%, its Return on Equity (ROE) is 9.00%, and its Return on Assets is 2.60%. All told, it is clear that, CME needs to be on your watchlist.

Find out when CME reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. CME has a short ratio of 2.99 and outstanding shares of 357.52M.

Company Outlook

CME has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 1.34 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at 6.66. CME Group Inc. CME also noted assets of $137.93 billion at the end of the last quarter. Investors should also keep an eye on sector updates as CME has historically followed its peers on positive news.

All told, CME Group Inc. CME has strung together solid data and demonstrated underlying fundamentals. At its current valuation, CME represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.

CME Group Inc. CME is now commanding a market cap of 60.13B and a float of 353.17M. CME is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of CME stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in CME, either long or short, and we have not been compensated for this article.

Post Views: 71

Chris Dziadul Reports: CME sale update

What is the latest on the controversial takeover of Central European Media Enterprises (CME) by the Czech Republic’s PPF Group? CME’s most recent …

What is the latest on the controversial takeover of Central European Media Enterprises (CME) by the Czech Republic’s PPF Group?

CME’s most recent results, published earlier this week, say that it remains on track and should be completed before October 27. This will be exactly a year since the $2.1 billion deal was first announced.

Although CME points out that its sale has been approved by shareholders and already received regulatory approval in Romania and Slovenia, obstacles could still remain. Back in February, before the Covid-19 pandemic effectively brought the world to a standstill, US Senator Marco Rubio asked for it to be investigated by the Committee on Foreign Investments in the United States (CFIUS). In his view, such an investigation was warranted as CME is a subsidiary of a US company (AT&T) and its sale would undermine US national security interests in Central and Eastern Europe (CEE).

PPF Group stood accused of working on behalf of China, where it has significant investments, and helping spread its influence in CEE. This it strongly denied, arguing that it was only buying CME to complement its telecom business.

While we have since not heard anything about the proposed investigation, there have been other important developments related to PPF Group. According to Bloomberg, its owner Petr Kellner has effectively lost $2.5 billion so far this year due to the pandemic and the collapse in the value of his stake in the China-based but Dutch registered consumer lender Home Credit, now worth an estimated $2.8 billion. Kellner’s fortune nevertheless still stands at a healthy $10 billion and he is expected to recover his losses in the short to medium term.

As for the sale of CME, unless some last-minute political pressure is brought to bear, it still looks likely to be completed before the end of October.

For more information about Chris Dziadul, please visit https://www.chrisdziadul.com

Related

Institutional Investors Lead Shift in Cme Group Inc (NASDAQ:CME) Sentiment

Cme Group Inc (NASDAQ:CME) institutional sentiment decreased to 0.99 in Q2 2019. Its down -0.01, from 1 in 2019Q1. The ratio worsened, as 301 …

CME Group Inc. (NASDAQ:CME) Logo

Sentiment for Cme Group Inc (NASDAQ:CME)

Cme Group Inc (NASDAQ:CME) institutional sentiment decreased to 0.99 in Q2 2019. Its down -0.01, from 1 in 2019Q1. The ratio worsened, as 301 investment professionals started new and increased stock positions, while 305 decreased and sold their equity positions in Cme Group Inc. The investment professionals in our partner’s database now possess: 284.49 million shares, up from 282.94 million shares in 2019Q1. Also, the number of investment professionals holding Cme Group Inc in their top 10 stock positions increased from 18 to 23 for an increase of 5. Sold All: 39 Reduced: 266 Increased: 230 New Position: 71.

CME Group Inc., through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. The company has market cap of $73.70 billion. The firm offers a range of products across various asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals. It has a 40.13 P/E ratio. The Company’s products include exchange-traded; and privately negotiated futures and options contracts and swaps.

The stock increased 0.20% or $0.42 during the last trading session, reaching $205.8. About 974,804 shares traded. CME Group Inc. (NASDAQ:CME) has risen 21.77% since September 14, 2018 and is uptrending. It has outperformed by 21.77% the S&P500.

Analysts await CME Group Inc. (NASDAQ:CME) to report earnings on October, 24. They expect $1.64 EPS, up 13.10 % or $0.19 from last year’s $1.45 per share. CME’s profit will be $587.28M for 31.37 P/E if the $1.64 EPS becomes a reality. After $1.76 actual EPS reported by CME Group Inc. for the previous quarter, Wall Street now forecasts -6.82 % negative EPS growth.

Vgi Partners Ltd holds 18.59% of its portfolio in CME Group Inc. for 1.13 million shares. Iron Financial Llc owns 96,736 shares or 14.86% of their US portfolio. Moreover, Capital Counsel Llc Ny has 11.51% invested in the company for 885,210 shares. The Ohio-based Cincinnati Financial Corp has invested 7.12% in the stock. Thornburg Investment Management Inc, a New Mexico-based fund reported 2.83 million shares.

CME Group Inc. (NASDAQ:CME) Ratings Coverage

Ratings analysis reveals 40% of CME Group’s analysts are positive. Out of 5 Wall Street analysts rating CME Group, 2 give it “Buy”, 1 “Sell” rating, while 2 recommend “Hold”. The lowest target is $150 while the high is $24000. The stock’s average target of $199.40 is -3.11% below today’s ($205.8) share price. CME was included in 14 notes of analysts from March 15, 2019. The rating was maintained by Deutsche Bank on Friday, August 9 with “Buy”. As per Tuesday, March 26, the company rating was maintained by Barclays Capital. The rating was maintained by J.P. Morgan with “Sell” on Friday, March 22. UBS maintained CME Group Inc. (NASDAQ:CME) rating on Wednesday, July 3. UBS has “Neutral” rating and $19400 target. UBS maintained the stock with “Neutral” rating in Thursday, September 5 report. On Thursday, May 2 the stock rating was maintained by UBS with “Neutral”. On Wednesday, July 3 the stock rating was maintained by Wells Fargo with “Market Perform”. The rating was maintained by UBS on Wednesday, June 5 with “Neutral”. The stock of CME Group Inc. (NASDAQ:CME) has “Buy” rating given on Friday, March 15 by Deutsche Bank.

More notable recent CME Group Inc. (NASDAQ:CME) news were published by: Nasdaq.com which released: “Canadian Metals Receives Shareholder Approval for Share Consolidation – Nasdaq” on September 04, 2019, also Nasdaq.com with their article: “4 Stocks to Play After Trade Talks Are Set to Resume – Nasdaq” published on September 05, 2019, Nasdaq.com published: “Why CME Group Stock Rose 12% in August – Nasdaq” on September 10, 2019. More interesting news about CME Group Inc. (NASDAQ:CME) were released by: Nasdaq.com and their article: “CME Group (CME) February ADV Drops at Six Products Lines – Nasdaq” published on March 05, 2019 as well as Nasdaq.com‘s news article titled: “Notable Tuesday Option Activity: NEM, BBY, CME – Nasdaq” with publication date: August 13, 2019.

CME Group Inc. (NASDAQ:CME) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Envestnet Asset Management Inc. Purchases 110159 Shares of CME Group Inc (NASDAQ:CME)

Envestnet Asset Management Inc. raised its holdings in CME Group Inc (NASDAQ:CME) by 110.9% in the 2nd quarter, according to its most recent …

CME Group logoEnvestnet Asset Management Inc. raised its holdings in CME Group Inc (NASDAQ:CME) by 110.9% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 209,516 shares of the financial services provider’s stock after buying an additional 110,159 shares during the quarter. Envestnet Asset Management Inc. owned approximately 0.06% of CME Group worth $40,669,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of CME. Lourd Capital LLC grew its stake in shares of CME Group by 3.5% in the second quarter. Lourd Capital LLC now owns 1,620 shares of the financial services provider’s stock valued at $314,000 after buying an additional 55 shares in the last quarter. Garner Asset Management Corp grew its stake in CME Group by 1.1% in the second quarter. Garner Asset Management Corp now owns 5,200 shares of the financial services provider’s stock worth $1,009,000 after purchasing an additional 55 shares in the last quarter. First Citizens Bank & Trust Co. boosted its holdings in CME Group by 0.3% in the second quarter. First Citizens Bank & Trust Co. now owns 22,092 shares of the financial services provider’s stock worth $4,289,000 after purchasing an additional 59 shares during the period. 6 Meridian increased its stake in CME Group by 2.4% during the second quarter. 6 Meridian now owns 2,700 shares of the financial services provider’s stock valued at $524,000 after purchasing an additional 62 shares during the last quarter. Finally, Contravisory Investment Management Inc. increased its stake in CME Group by 22.9% during the second quarter. Contravisory Investment Management Inc. now owns 344 shares of the financial services provider’s stock valued at $67,000 after purchasing an additional 64 shares during the last quarter. Institutional investors own 84.99% of the company’s stock.

A number of research firms have recently issued reports on CME. Deutsche Bank raised their price target on shares of CME Group from $224.00 to $240.00 and gave the stock a “buy” rating in a research report on Friday, August 9th. Zacks Investment Research lowered shares of CME Group from a “hold” rating to a “sell” rating and set a $158.00 price objective on the stock. in a research note on Monday, May 27th. Wells Fargo & Co raised their target price on shares of CME Group from $176.00 to $200.00 and gave the stock a “market perform” rating in a report on Wednesday, July 3rd. BidaskClub upgraded CME Group from a “hold” rating to a “buy” rating in a research note on Friday, August 9th. Finally, Barclays increased their price target on CME Group from $191.00 to $197.00 and gave the stock an “overweight” rating in a research report on Thursday, May 23rd. Three analysts have rated the stock with a sell rating, five have assigned a hold rating and eight have assigned a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of $196.85.

In other news, CFO John W. Pietrowicz sold 2,500 shares of the stock in a transaction on Wednesday, September 4th. The stock was sold at an average price of $217.62, for a total transaction of $544,050.00. Following the completion of the sale, the chief financial officer now owns 30,354 shares in the company, valued at approximately $6,605,637.48. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Derek Sammann sold 6,400 shares of CME Group stock in a transaction on Wednesday, June 12th. The stock was sold at an average price of $198.83, for a total value of $1,272,512.00. Following the completion of the transaction, the insider now owns 25,177 shares in the company, valued at $5,005,942.91. The disclosure for this sale can be found here. Insiders have sold a total of 58,826 shares of company stock valued at $11,921,910 in the last quarter. 1.20% of the stock is currently owned by insiders.

NASDAQ CME traded down $7.49 on Monday, hitting $215.58. The stock had a trading volume of 931,144 shares, compared to its average volume of 1,560,810. The company’s 50-day moving average is $211.18 and its two-hundred day moving average is $190.75. The stock has a market cap of $79.20 billion, a price-to-earnings ratio of 31.61, a P/E/G ratio of 4.93 and a beta of 0.19. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.15. CME Group Inc has a one year low of $161.05 and a one year high of $224.91.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.75 by $0.01. CME Group had a return on equity of 9.14% and a net margin of 39.36%. The business had revenue of $1.27 billion during the quarter, compared to the consensus estimate of $1.27 billion. During the same period in the previous year, the firm posted $1.74 earnings per share. The business’s revenue was up 20.1% on a year-over-year basis. On average, sell-side analysts anticipate that CME Group Inc will post 6.69 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Tuesday, September 10th will be given a dividend of $0.75 per share. The ex-dividend date is Monday, September 9th. This represents a $3.00 dividend on an annualized basis and a yield of 1.39%. CME Group’s dividend payout ratio (DPR) is presently 43.99%.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Read More: How much can an individual set aside as a catch-up contribution?

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.

Elkfork Partners LLC Raises Position in CME Group Inc (NASDAQ:CME)

Elkfork Partners LLC raised its holdings in CME Group Inc (NASDAQ:CME) by 8.8% in the 2nd quarter, HoldingsChannel.com reports. The institutional …

CME Group logoElkfork Partners LLC raised its holdings in CME Group Inc (NASDAQ:CME) by 8.8% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 249,648 shares of the financial services provider’s stock after acquiring an additional 20,132 shares during the quarter. CME Group comprises approximately 1.2% of Elkfork Partners LLC’s investment portfolio, making the stock its 15th largest holding. Elkfork Partners LLC’s holdings in CME Group were worth $48,459,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Advantage Investment Management LLC lifted its position in shares of CME Group by 119.0% during the 2nd quarter. Advantage Investment Management LLC now owns 184 shares of the financial services provider’s stock worth $36,000 after purchasing an additional 100 shares during the last quarter. Westside Investment Management Inc. acquired a new stake in CME Group during the 2nd quarter worth $38,000. Close Asset Management Ltd acquired a new stake in CME Group during the 1st quarter worth $34,000. Permanens Capital L.P. acquired a new stake in CME Group during the 1st quarter worth $41,000. Finally, Patriot Financial Group Insurance Agency LLC raised its stake in CME Group by 209.4% during the 2nd quarter. Patriot Financial Group Insurance Agency LLC now owns 263 shares of the financial services provider’s stock worth $53,000 after acquiring an additional 178 shares in the last quarter. 85.72% of the stock is owned by institutional investors.

NASDAQ CME opened at $223.07 on Friday. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.05 and a current ratio of 1.05. The firm has a market cap of $79.20 billion, a PE ratio of 32.71, a P/E/G ratio of 4.93 and a beta of 0.19. CME Group Inc has a one year low of $161.05 and a one year high of $224.91. The firm’s fifty day moving average is $210.24 and its two-hundred day moving average is $190.06.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $1.76 EPS for the quarter, beating analysts’ consensus estimates of $1.75 by $0.01. The company had revenue of $1.27 billion for the quarter, compared to analyst estimates of $1.27 billion. CME Group had a net margin of 39.36% and a return on equity of 9.14%. CME Group’s quarterly revenue was up 20.1% on a year-over-year basis. During the same period in the previous year, the business posted $1.74 earnings per share. Research analysts predict that CME Group Inc will post 6.69 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Tuesday, September 10th will be paid a $0.75 dividend. The ex-dividend date is Monday, September 9th. This represents a $3.00 dividend on an annualized basis and a yield of 1.34%. CME Group’s dividend payout ratio is presently 43.99%.

Several equities research analysts recently commented on the stock. UBS Group lifted their price target on shares of CME Group from $191.00 to $214.00 and gave the stock a “neutral” rating in a research note on Thursday. Wells Fargo & Co lifted their price target on shares of CME Group from $176.00 to $200.00 and gave the stock a “market perform” rating in a research note on Wednesday, July 3rd. Zacks Investment Research lowered shares of CME Group from a “hold” rating to a “sell” rating and set a $158.00 price target on the stock. in a research note on Monday, May 27th. BidaskClub upgraded shares of CME Group from a “hold” rating to a “buy” rating in a research note on Friday, August 9th. Finally, Deutsche Bank lifted their price target on shares of CME Group from $224.00 to $240.00 and gave the stock a “buy” rating in a research note on Friday, August 9th. Three investment analysts have rated the stock with a sell rating, five have assigned a hold rating and eight have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of $196.85.

In other CME Group news, insider Derek Sammann sold 6,400 shares of CME Group stock in a transaction on Wednesday, June 12th. The shares were sold at an average price of $198.83, for a total value of $1,272,512.00. Following the transaction, the insider now directly owns 25,177 shares in the company, valued at $5,005,942.91. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO John W. Pietrowicz sold 2,500 shares of CME Group stock in a transaction on Wednesday, September 4th. The shares were sold at an average price of $217.62, for a total transaction of $544,050.00. Following the completion of the transaction, the chief financial officer now owns 30,354 shares in the company, valued at $6,605,637.48. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 59,126 shares of company stock worth $11,983,191. 1.20% of the stock is currently owned by company insiders.

CME Group Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

See Also: What is the CBOE Russell 2000® Volatility Index?

Want to see what other hedge funds are holding CME?Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.